Author:
Albizua Enriqueta,Gallardo Miguel,Barrio Santiago,Rapado Inmaculada,Jimenez Ana,Ayala Rosa,Rueda Daniel,Sanchez-Espiridion Beatriz,Puigdecanet Eulalia,Espinet Blanca,Florensa Lourdes,Besses Carles,Martinez-Lopez Joaquin
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference26 articles.
1. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144–1148
2. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 8:8
3. Barosi G, Birgegard G, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC et al (2009) Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. Blood 113(20):4829–4833
4. Goldman JM, Green AR, Holyoake T, Jamieson C, Mesa R, Mughal T et al (2009) Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia 23:1708–1715
5. Levine RL, Belisle C, Wadleigh M, Zahrieh D, Lee S, Chagnon P et al (2006) X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis. Blood 107(10):4139–4141, Epub 2006 Jan 24
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献